Answer Questions About Once-Weekly Rezafungin

September 2023

IV rezafungin (Rezzayo) will be the first once-WEEKLY echinocandin.

It’s approved for candidemia and invasive candidiasis...and will compete with once-DAILY anidulafungin, caspofungin, and micafungin.

Rezafungin seems as effective as caspofungin for reducing mortality and achieving clinical cure of candidemia or invasive candidiasis.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote